Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • KateShepard
    Junior Member
    • Apr 2016
    • 5

    biological replicates cuffmerge?

    Dear forum,

    I have 5 RNA-seq biological replicates and wish to examine the expression levels of specific genes/pathways of interest (high/low/not expressed) (no differential expression analysis).

    I have mapped all samples to the appropriate ref genome/annotation using tophat2 and have assembled transcriptomes using cufflinks.

    My question is now should I merge the 5 cufflinks assemblies together using cuffmerge, and use the merged assembly as my master transcriptome?

    Also, is there a good tool/approach to visualise the variability between my biological replicates?

    Thank you for your advice
    Kate
  • fanli
    Senior Member
    • Jul 2014
    • 197

    #2
    Originally posted by KateShepard View Post
    My question is now should I merge the 5 cufflinks assemblies together using cuffmerge, and use the merged assembly as my master transcriptome?
    Yes, that's the intended purpose of cuffmerge.

    Originally posted by KateShepard View Post
    Also, is there a good tool/approach to visualise the variability between my biological replicates?
    PCA, heatmaps, and clustering are useful for examining variability in your replicates. Check out the DESeq2 or edgeR packages for details.

    Comment

    • Michael.Ante
      Senior Member
      • Oct 2011
      • 127

      #3
      In addition to fanli's post, you should have a look at the cummeRbund package for R. It was designed by the Cufflinks group and has some tailored analysis/visualisations for Cufflinks results.

      Cheers,
      Michael

      Comment

      • KateShepard
        Junior Member
        • Apr 2016
        • 5

        #4
        CummeRbund for one condition (multiple biological replicates)

        Thank you for your replies.

        CummeRbund looks extremely useful, however I am having trouble working out how to use Cufflink data which originates from one condition only (multiple biological replicates). It seems like you can only use the output from cuffdiff which compares two conditions.

        Do you know an approach for visualising data from one condition?

        Thanks,
        Kate

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 12:17 PM
        0 responses
        10 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        11 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        37 views
        0 reactions
        Last Post SEQadmin2  
        Working...